Assembly Biosciences ASMB Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Assembly Biosciences’s reported figures.
Based on trailing twelve months.
The official record: Assembly Biosciences’s 10-Q, filed November 10, 2025, on SEC EDGAR. View the filing →
Ask your AI about Assembly Biosciences's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Assembly Biosciences's return on equity?
- Assembly Biosciences (ASMB) reported return on equity of -36.9% in Q3 2025.
- How has Assembly Biosciences's return on equity changed year-over-year?
- Assembly Biosciences's return on equity increased by 69.3% year-over-year, from -120.5% to -36.9%.
- What is the long-term trend for Assembly Biosciences's return on equity?
- Over 4 years (2020 to 2024), Assembly Biosciences's return on equity has grown at a 45.3% compound annual growth rate (CAGR), from -24.2% to -107.9%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.